Invention Grant
US08440661B2 Methods of modulating inflammatory cell recruitment and gene expression using haloaryl substituted aminopurines
有权
使用卤代芳基取代氨基嘌呤调节炎性细胞募集和基因表达的方法
- Patent Title: Methods of modulating inflammatory cell recruitment and gene expression using haloaryl substituted aminopurines
- Patent Title (中): 使用卤代芳基取代氨基嘌呤调节炎性细胞募集和基因表达的方法
-
Application No.: US12779083Application Date: 2010-05-13
-
Publication No.: US08440661B2Publication Date: 2013-05-14
- Inventor: Brydon L. Bennett , Kate Northcote , Brian Edwin Cathers
- Applicant: Brydon L. Bennett , Kate Northcote , Brian Edwin Cathers
- Applicant Address: US CA San Diego
- Assignee: Signal Pharmaceuticals, LLC
- Current Assignee: Signal Pharmaceuticals, LLC
- Current Assignee Address: US CA San Diego
- Agency: Jones Day
- Main IPC: A61P11/00
- IPC: A61P11/00 ; C07D473/32 ; C07D239/50 ; C07D239/48 ; A61K31/53 ; A61P3/10

Abstract:
Provided herein are Aminopurine Compounds having the following structure: wherein R1, R2 and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound and methods for treating or preventing cancer, a cardiovascular disease, a renal disease, an autoimmune condition, an inflammatory condition, macular degeneration, ischemia-reperfusion injury, pain and related syndromes, disease-related wasting, an asbestos-related condition, pulmonary hypertension or a condition treatable or preventable by inhibition of the JNK pathway comprising administering an effective amount of an Aminopurine Compound to a patient in need thereof.
Public/Granted literature
Information query